Home > Products > CD3 & DLL3
> Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (Tandem Diabody)
Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-076)
Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget T cells to tumor cells. It is designed for the research of Lung cancer; Pancreatic cancer; Skin cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-DLL3 Bispecific Antibody (Tandem Diabody) (T-BSDB-076). Click the button below to contact us or submit your feedback about this product.